HilleVax Inc is a clinical-stage biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
HLVX is expected to report earnings to fall 57.35% to -28 cents per share on August 07
Q2'25
Est.
$-0.29
Q4'24
Missed
by $0.37
Q3'24
Missed
by $0.10
Q2'24
Missed
by $0.05
Q1'24
Missed
by $0.16
The last earnings report on March 28 showed earnings per share of -68 cents, missing the estimate of -30 cents. With 101.20K shares outstanding, the current market capitalization sits at 97.95M.